COGT (Cogent Biosciences) FFO


COGT Cogent Biosciences Inc COGT
25 GF Score
Price $37.53
! 3 Warning Signs
View Full Analysis

What is Cogent Biosciences FFO?

FFO (Funds from operations) only applies to REITs.

COGT
25GF Score
Cogent Biosciences Inc COGT
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cogent Biosciences Business Description

Address 275 Wyman Street, 3rd Floor, Waltham, MA, USA, 02451
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
25GF Score

Get the complete analysis for COGT

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$37.53
Price